Order Entry
Austria
ContactUsLinkComponent
Human Recombinant IL-37
  STMC100-1320
 :  
undefined
Human Recombinant IL-37
  STMC100-1320
 :  

 

  • VE:
    100 µG
  • Protein/Peptid-Typ:
    Rekombinant
  • Spezies:
    Human
  • Proteinsynonym:
    FIL1|FIL1(ZETA)|FIL1Z|IL1F7|IL-1F7|IL-1H|IL1H4|IL-1H4|IL1RP1|IL-1RP1|IL37
  • Protein/Peptid-Name:
    IL-37
  • Purity:
    ≥93%

 

 

Use Interleukin 37 (IL-37) to inhibit the expression of inflammatory cytokines, such as IL-6, MIP-1α, MIP-1β, and TNF-α, in a MAPK-dependent manner (Qi et al.). A secreted protein belonging to the interleukin-1 cytokine family, IL-37 acts as an anti-inflammatory alarmin, with predominant expression in monocytes, and constitutive secretion by myeloid dendritic cells (Rudloff et al.). IL-37 has been shown to limit inflammation in human blood M1 macrophages by binding to extracellular surface receptors, requiring IL-1R8 as a coreceptor (Li et al.). It also has protective effects against obesity-induced inflammation and insulin resistance, reducing adipogenesis and activating AMPK signaling both in vitro and in vivo (Ballak et al.). In humans, the IL-37 gene undergoes alternative splicing, resulting in multiple isoforms of the protein (Boraschi et al.). For consistency and reproducibility across your applications, Interleukin 37 from STEMCELL comes lyophilised with ≥93% purity.

 : Product restrictions: (i) Customer shall not make products or any portion of them in any way, shape or form, including as a component of another product available for the purpose of further resale or alter or remove the Product label and the Supplier’s mark of origin without express written permission of Supplier and (ii) Customer is familiar with Supplier’s restrictions on the use of the products and shall use the products in compliance with such restrictions and the applicable Supplier Product Information sheet (collectively, the 'Product Restrictions').